Aptus takes $30M to repair aneurysms
Aptus Endosystems, a biotech firm working on a device to fix abdominal aneurysms, just brought in $30 million in third-round funding to finish off clinical trials of its Abdominal Aortic Aneurysm Repair System, reports VentureWire. Heron Capital led the round, which also included Longitude Capital,… Continue Reading
Life sciences briefing: Wednesday, Aug. 29, 2007
(UPDATED at 3:10pm PT: See below.)
Featured companies: Agendia, EndoGastric Solutions, FlowCo, Gentris, MedManage Systems, ParagonDx, Presidio Pharmaceuticals, Xoova
Presidio Pharma raises $26M for viral treatments — San Francisco’s Presidio Pharmaceuticals, a biotech developing new antiviral drugs, raised $26 million in a second funding round. Investors included Panorama… Continue Reading
Cytyc to buy women’s contraception company, Adiana, for up to $215M
Cytyc Corporation, a publicly traded company targeting women’s health and cancer diagnostics, said it has agreed to acquire Adiana, a venture-backed Redwood City company that has developed a “non-incisional alternative to tubal ligation” for permanent contraception for women.
Cytyc, based in Marlborough, Mass., will make an… Continue Reading